Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy.

Saved in:
Bibliographic Details
Title: Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy.
Authors: Shellard JPG; Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom., Carr E; Institute for Infection and Immunity, City St George's, University of London, London, United Kingdom., Tam-McMillan G; Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom., Mao EW; Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom., Mujuru H; Department of Paediatrics, University of Zimbabwe, Harare, Zimbabwe., Banda Mabuda H; University Teaching Hospital, Women and Newborn Hospital, University of Zambia, Lusaka, Zambia., Chisenga M; University Teaching Hospital, Women and Newborn Hospital, University of Zambia, Lusaka, Zambia., Bandason T; Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe., Dzavakwa NV; Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.; International Statistics and Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom., Kasonka L; University Teaching Hospital, Women and Newborn Hospital, University of Zambia, Lusaka, Zambia., Simms V; Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.; International Statistics and Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom., Gregson CL; Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.; Global Musculoskeletal Research Group, Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Ferrand RA; Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Rowland-Jones SL; Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom., Hsieh AYY; Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom.; Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Source: The Journal of infectious diseases [J Infect Dis] 2026 Jun 16; Vol. 233 (6), pp. e1407-e1417.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6613
DOI:10.1093/infdis/jiag060